AMY WARCHOL: Open Payments
NPI 1730815911 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 22 payments from 13 companies in 2025. Trend: 2023 $41 · 2024 $189 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| ABBVIE INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| BioMarin Pharmaceutical Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, Ozempic, QULIPTA, JARDIANCE, BREZTRI, VOXZOGO 1.2mg, Cologuard Collection Kit, Wegovy.
Industry payments across OH — which companies pay providers there.
